| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC0931 |
| Trial ID | ChiCTR2100046763 |
| Disease | Hematologic Cancer |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, open-label and single-arm clinical research of chimeric antigen receptor T cells in the treatment of relapsed and refractory CD30-positive hemalogical maligancies |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Nanchang University |
| Cohort 1 | |||||||
|
|||||||